These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 8352281)
21. The Role of Dermal Fibroblasts in Nevoid Basal Cell Carcinoma Syndrome Patients: An Overview. Bellei B; Caputo S; Carbone A; Silipo V; Papaccio F; Picardo M; Eibenschutz L Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979112 [TBL] [Abstract][Full Text] [Related]
22. Somatic mutations in the human homologue of Drosophila patched in primitive neuroectodermal tumours. Vorechovský I; Tingby O; Hartman M; Strömberg B; Nister M; Collins VP; Toftgård R Oncogene; 1997 Jul; 15(3):361-6. PubMed ID: 9233770 [TBL] [Abstract][Full Text] [Related]
23. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations. Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761 [TBL] [Abstract][Full Text] [Related]
24. Involvement of patched (PTCH) gene in Gorlin syndrome and related disorders: three family cases. Situm M; Levanat S; Crnic I; Pavelic B; Macan D; Grgurević J; Mubrin-Koncar M; Lipozencić J Croat Med J; 1999 Dec; 40(4):533-8. PubMed ID: 10554356 [TBL] [Abstract][Full Text] [Related]
26. The gene for the naevoid basal cell carcinoma syndrome acts as a tumour-suppressor gene in medulloblastoma. Cowan R; Hoban P; Kelsey A; Birch JM; Gattamaneni R; Evans DG Br J Cancer; 1997; 76(2):141-5. PubMed ID: 9231911 [TBL] [Abstract][Full Text] [Related]
27. Biallelic alterations of the large tumor suppressor 1 (LATS1) gene in infiltrative, but not superficial, basal cell carcinomas in a Japanese patient with nevoid basal cell carcinoma syndrome. Tate G; Kishimoto K; Mitsuya T Med Mol Morphol; 2015 Sep; 48(3):177-82. PubMed ID: 25119020 [TBL] [Abstract][Full Text] [Related]
28. [A nevoid basal cell carcinoma syndrome with chromosomal aberration]. Sasaki K; Yoshimoto T; Nakao T; Minagawa K; Takahashi Y; Watanabe Y; Tanabe C No To Hattatsu; 2000 Jan; 32(1):49-55. PubMed ID: 10655752 [TBL] [Abstract][Full Text] [Related]
29. Location of gene for Gorlin syndrome. Farndon PA; Del Mastro RG; Evans DG; Kilpatrick MW Lancet; 1992 Mar; 339(8793):581-2. PubMed ID: 1347096 [TBL] [Abstract][Full Text] [Related]
30. Shh and p50/Bcl3 signaling crosstalk drives pathogenesis of BCCs in Gorlin syndrome. Chaudhary SC; Tang X; Arumugam A; Li C; Srivastava RK; Weng Z; Xu J; Zhang X; Kim AL; McKay K; Elmets CA; Kopelovich L; Bickers DR; Athar M Oncotarget; 2015 Nov; 6(34):36789-814. PubMed ID: 26413810 [TBL] [Abstract][Full Text] [Related]
31. The human growth-arrest-specific gene GAS1 maps outside the candidate region of the gene for nevoid basal cell carcinoma syndrome. Wicking C; Breen M; Negus K; Berkman J; Evdokiou A; Cowled P; Chenevix-Trench G; Wainwright B Cytogenet Cell Genet; 1995; 68(1-2):119-21. PubMed ID: 7956349 [TBL] [Abstract][Full Text] [Related]
32. Parental origin of chromosome 9q22.3-q31 lost in basal cell carcinomas from basal cell nevus syndrome patients. Bonifas JM; Bare JW; Kerschmann RL; Master SP; Epstein EH Hum Mol Genet; 1994 Mar; 3(3):447-8. PubMed ID: 8012356 [TBL] [Abstract][Full Text] [Related]
33. Biallelic disruption of the PTCH1 gene in multiple basal cell carcinomas in Japanese patients with nevoid basal cell carcinoma syndrome. Tate G; Kishimoto K; Mitsuya T Acta Med Okayama; 2014; 68(3):163-70. PubMed ID: 24942795 [TBL] [Abstract][Full Text] [Related]
34. Identification of genetic loci for basal cell nevus syndrome and inflammatory bowel disease in a single large pedigree. Panhuysen CI; Karban A; Knodle Manning A; Bayless TM; Duerr RH; Bailey-Wilson JE; Epstein EH; Brant SR Hum Genet; 2006 Aug; 120(1):31-41. PubMed ID: 16733713 [TBL] [Abstract][Full Text] [Related]
35. NBCCS secondary to an interstitial chromosome 9q deletion. Haniffa MA; Leech SN; Lynch SA; Simpson NB Clin Exp Dermatol; 2004 Sep; 29(5):542-4. PubMed ID: 15347344 [TBL] [Abstract][Full Text] [Related]
36. Detailed deletion mapping of chromosome 9q in bladder cancer: evidence for two tumour suppressor loci. Habuchi T; Devlin J; Elder PA; Knowles MA Oncogene; 1995 Oct; 11(8):1671-4. PubMed ID: 7478593 [TBL] [Abstract][Full Text] [Related]
37. Variable expression of Gorlin syndrome may reflect complexity of the signalling pathway. Levanat S; Mubrin MK; Crnić I; Situm M; Basta-Juzbasić A Pflugers Arch; 2000; 439(3 Suppl):R31-3. PubMed ID: 10653132 [TBL] [Abstract][Full Text] [Related]
38. Nevoid basal cell carcinoma syndrome: review of 118 affected individuals. Shanley S; Ratcliffe J; Hockey A; Haan E; Oley C; Ravine D; Martin N; Wicking C; Chenevix-Trench G Am J Med Genet; 1994 Apr; 50(3):282-90. PubMed ID: 8042673 [TBL] [Abstract][Full Text] [Related]
39. Loss of heterozygosity at chromosome 1q22 in basal cell carcinomas and exclusion of the basal cell nevus syndrome gene from this site. Bare JW; Lebo RV; Epstein EH Cancer Res; 1992 Mar; 52(6):1494-8. PubMed ID: 1540957 [TBL] [Abstract][Full Text] [Related]
40. Gorlin syndrome associated with basal cell carcinoma of the vulva: A case report. Giuliani M; Di Stefano L; Zoccali G; Angelone E; Leocata P; Mascaretti G Eur J Gynaecol Oncol; 2006; 27(5):519-22. PubMed ID: 17139991 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]